These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

778 related items for PubMed ID: 1934265

  • 1. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.
    Turesky RJ, Lang NP, Butler MA, Teitel CH, Kadlubar FF.
    Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265
    [Abstract] [Full Text] [Related]

  • 2. Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes.
    Kaderlik KR, Mulder GJ, Turesky RJ, Lang NP, Teitel CH, Chiarelli MP, Kadlubar FF.
    Carcinogenesis; 1994 Aug; 15(8):1695-701. PubMed ID: 8055651
    [Abstract] [Full Text] [Related]

  • 3. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
    Snyderwine EG, Turesky RJ, Buonarati MH, Turteltaub KW, Adamson RH.
    Princess Takamatsu Symp; 1995 Aug; 23():69-77. PubMed ID: 8844797
    [Abstract] [Full Text] [Related]

  • 4. Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.
    Hein DW, Flammang TJ, Kirlin WG, Trinidad A, Ogolla F.
    Carcinogenesis; 1987 Dec; 8(12):1767-74. PubMed ID: 3677303
    [Abstract] [Full Text] [Related]

  • 5. Enzymatic phase II activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats.
    Davis CD, Schut HA, Snyderwine EG.
    Carcinogenesis; 1993 Oct; 14(10):2091-6. PubMed ID: 8222059
    [Abstract] [Full Text] [Related]

  • 6. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.
    Edwards RJ, Murray BP, Murray S, Schulz T, Neubert D, Gant TW, Thorgeirsson SS, Boobis AR, Davies DS.
    Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW, Doll MA, Gray K, Rustan TD, Ferguson RJ.
    Cancer Res; 1993 Feb 01; 53(3):509-14. PubMed ID: 8425184
    [Abstract] [Full Text] [Related]

  • 10. Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis.
    Lin D, Meyer DJ, Ketterer B, Lang NP, Kadlubar FF.
    Cancer Res; 1994 Sep 15; 54(18):4920-6. PubMed ID: 8069858
    [Abstract] [Full Text] [Related]

  • 11. Interindividual variation in the metabolic activation of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells.
    Stone EM, Williams JA, Grover PL, Gusterson BA, Phillips DH.
    Carcinogenesis; 1998 May 15; 19(5):873-9. PubMed ID: 9635877
    [Abstract] [Full Text] [Related]

  • 12. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
    Chou HC, Lang NP, Kadlubar FF.
    Cancer Res; 1995 Feb 01; 55(3):525-9. PubMed ID: 7834621
    [Abstract] [Full Text] [Related]

  • 13. Metabolic activation of heterocyclic amine food mutagens in the mammary gland of lactating Fischer 344 rats.
    Davis CD, Ghoshal A, Schut HA, Snyderwine EG.
    Cancer Lett; 1994 Aug 29; 84(1):67-73. PubMed ID: 7915639
    [Abstract] [Full Text] [Related]

  • 14. Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice.
    Lin DX, Lang NP, Kadlubar FF.
    Drug Metab Dispos; 1995 Apr 29; 23(4):518-24. PubMed ID: 7600922
    [Abstract] [Full Text] [Related]

  • 15. Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo.
    Davis CD, Schut HA, Adamson RH, Thorgeirsson UP, Thorgeirsson SS, Snyderwine EG.
    Carcinogenesis; 1993 Jan 29; 14(1):61-5. PubMed ID: 8425272
    [Abstract] [Full Text] [Related]

  • 16. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
    Sadrieh N, Snyderwine EG.
    Carcinogenesis; 1995 Jul 29; 16(7):1549-55. PubMed ID: 7614688
    [Abstract] [Full Text] [Related]

  • 17. Possible relationship between tissue distribution of DNA adducts and genotoxicity of food-derived heterocyclic amines.
    Thorgeirsson SS, Davis CD, Schut HA, Adamson RH, Snyderwine EG.
    Princess Takamatsu Symp; 1995 Jul 29; 23():85-92. PubMed ID: 8844799
    [Abstract] [Full Text] [Related]

  • 18. N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells.
    Minchin RF, Reeves PT, Teitel CH, McManus ME, Mojarrabi B, Ilett KF, Kadlubar FF.
    Biochem Biophys Res Commun; 1992 Jun 30; 185(3):839-44. PubMed ID: 1627140
    [Abstract] [Full Text] [Related]

  • 19. Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines.
    Hellmold H, Overvik E, Strömstedt M, Gustafsson JA.
    Carcinogenesis; 1993 Sep 30; 14(9):1751-7. PubMed ID: 8403195
    [Abstract] [Full Text] [Related]

  • 20. Effect of N-acetyltransferase 2 polymorphism on tumor target tissue DNA adduct levels in rapid and slow acetylator congenic rats administered 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine or 2-amino-3,8-dimethylimidazo-[4,5-f]quinoxaline.
    Metry KJ, Neale JR, Bendaly J, Smith NB, Pierce WM, Hein DW.
    Drug Metab Dispos; 2009 Nov 30; 37(11):2123-6. PubMed ID: 19666988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.